Duloxetine to Prevent Chronic Postsurgical Pain After Inguinal Hernia Repair in Patients at High Risk

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

294

Participants

Timeline

Start Date

September 3, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions

Chronic Post-surgical Pain

Interventions

DRUG

Duloxetine

30 mg daily 2 weeks before surgery and 1 week after surgery

DRUG

Placebo

Placebo tablet daily

Trial Locations (1)

Hospital del Mar, Barcelona

All Listed Sponsors

collaborator

Carlos III Health Institute

OTHER_GOV

lead

Parc de Salut Mar

OTHER

NCT06606067 - Duloxetine to Prevent Chronic Postsurgical Pain After Inguinal Hernia Repair in Patients at High Risk | Biotech Hunter | Biotech Hunter